Human cardiomyocytes for drug discovery
Introduction: Cardiac drug discovery are based in old methods that use animals, animal cells or modified cells that do not faithfully represent human cardiac phenotypes. Objective: Here, we aimed to show that cardiomyocytes derived from human iPS cells represent a new tool for cardiac drug discovery...
Main Authors: | Diogo Gonçalves Biagi, Jéssica Gonçalves, Estela Cruvinel, Renata Damiani, Flavia Valgode, Fabiana Medeiros, Camila G Moreira, Evelyn Santos, Rodrigo Marcon, Calixto João, Gabriela Venturini, Alexandre Pereira, Éden Ferreira, Renato Mortara, Marcos C Valadares |
---|---|
Format: | Article |
Language: | English |
Published: |
Fundação Oswaldo Cruz (FIOCRUZ)
2018-02-01
|
Series: | Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia |
Subjects: | |
Online Access: | https://hm-visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1049 |
Similar Items
-
Human cardiomyocytes for drug discovery
by: Diogo Gonçalves Biagi, et al.
Published: (2018-02-01) -
Human cardiomyocytes for drug discovery
by: Diogo Gonçalves Biagi, et al.
Published: (2018-02-01) -
Human cardiomyocytes for drug discovery
by: Diogo Gonçalves Biagi, et al.
Published: (2018-02-01) -
The Effect of Doxorubicin on Viability and Morphology of Human Embryonic Stem Cell-derived Cardiomyocytes
by: Marziyeh Shalchi Tousi, et al.
Published: (2014-08-01) -
Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway
by: Jung Joo Yoon, et al.
Published: (2021-12-01)